"If the results are positive, AMRN shares will take a fall. Comsidering buying some out of the money puts on AMRN for next week."

Why do you think this? Amarin is so close to their PDUFA date and potential label expansion for cardio indication, I don't see Apabetalone/BETonMACE having much if any influence on Amarin. Resverlogix will have their own hoops to jump through if and when they file for their own NDA/MAA approvals.Amarin will have their decision from FDA before Resverlogix files their NDA/MAA. Quite a number of differences between Amarin/Vascepa/REDUCE-IT and Resverlogix/Apabetalone/BETonMACE. Some of these differences are listed here. 

BearDownAZ